Literature DB >> 20153352

Evaluation of Southern Hemisphere influenza vaccine recommendations.

Stephanie A Richard1, Cécile Viboud, Mark A Miller.   

Abstract

In 1999, the World Health Organization switched from annual to semi-annual recommendations for influenza vaccine composition. We compared the antigenic match between recommendations and circulating viruses before and after 1999, in the Northern and Southern Hemispheres. Vaccine match proportion for A/H3N2 viruses increased from 31% to 59% in the Southern Hemisphere (P<0.05), and is now comparable to that in the Northern Hemisphere. Vaccine match for influenza B decreased from approximately 100% to 33-54% in both hemispheres (P<0.05), following the unexpected resurgence of influenza B/Victoria in 1997. No estimate was available for influenza A/H1N1. We conclude that semi-annual vaccine recommendations are useful overall and discuss potential ways forward, including a recommendation for the improvement of vaccination policy and influenza surveillance in tropical areas. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153352      PMCID: PMC2844446          DOI: 10.1016/j.vaccine.2010.01.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  67 in total

1.  Predicting the evolution of human influenza A.

Authors:  R M Bush; C A Bender; K Subbarao; N J Cox; W M Fitch
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  Influenza in Canada--1998-1999 season.

Authors:  L Pelletier; P Buck; P Zabchuk; B Winchester; T Tam
Journal:  Can Commun Dis Rep       Date:  1999-11-15

3.  Update: influenza activity--worldwide, May-September 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-10-08       Impact factor: 17.586

4.  Influenza in Canada: 2005-2006 season.

Authors:  F Reyes; J F Macey; S Aziz; Y Li; K Watkins; B Winchester; P Zabchuck; H Zheng; P Huston; T W S Tam; T Hatchette
Journal:  Can Commun Dis Rep       Date:  2007-02-01

5.  Influenza in Canada--1995-1996 season.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1996-12-01

6.  Update: influenza activity--United States and Worldwide, 1995-96 season, and composition of the 1996-97 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-04-26       Impact factor: 17.586

7.  Influenza in Canada. 1994-1995 season.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1995-12-15

8.  Update: influenza activity--United States and worldwide, 1994-95 season, and composition of the 1995-96 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-04-21       Impact factor: 17.586

9.  Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics.

Authors:  Wladimir J Alonso; Cécile Viboud; Lone Simonsen; Eduardo W Hirano; Luciane Z Daufenbach; Mark A Miller
Journal:  Am J Epidemiol       Date:  2007-03-16       Impact factor: 4.897

Review 10.  Vaccines for preventing influenza in healthy adults.

Authors:  T O Jefferson; D Rivetti; C Di Pietrantonj; A Rivetti; V Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
View more
  17 in total

1.  Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Authors:  Yolanda D Mahnke; Areej Saqr; Staci Hazenfeld; Rebecca C Brady; Mario Roederer; Ramu A Subbramanian
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

2.  Children with special health care needs and preparedness: experiences from seasonal influenza and the 2009 H1N1 influenza pandemic.

Authors:  Georgina Peacock; Cynthia Moore; Timothy Uyeki
Journal:  Disaster Med Public Health Prep       Date:  2012-06       Impact factor: 1.385

3.  Mismatching between circulating strains and vaccine strains of influenza: Effect on Hajj pilgrims from both hemispheres.

Authors:  Mohammad Alfelali; Gulam Khandaker; Robert Booy; Harunor Rashid
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 4.  Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.

Authors:  Nicola Luigi Bragazzi; Andrea Orsi; Filippo Ansaldi; Roberto Gasparini; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2016-05-31       Impact factor: 3.452

Review 5.  Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly.

Authors:  Monique P Curran; Isabel Leroux-Roels
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

6.  Evolution of Influenza B Virus in Kuala Lumpur, Malaysia, between 1995 and 2008.

Authors:  I-Ching Sam; Yvonne C F Su; Yoke Fun Chan; Siti Sarah Nor'E; Ardalinah Hassan; Faizatul Lela Jafar; Udayan Joseph; Rebecca A Halpin; Elodie Ghedin; Poh Sim Hooi; Mathieu Fourment; Hamimah Hassan; Sazaly AbuBakar; David E Wentworth; Gavin J D Smith
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

7.  Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.

Authors:  Serge Durviaux; John Treanor; Jiri Beran; Xavier Duval; Meral Esen; Gregory Feldman; Sharon E Frey; Odile Launay; Geert Leroux-Roels; Janet E McElhaney; Andrzej Nowakowski; Guillermo M Ruiz-Palacios; Gerrit A van Essen; Lidia Oostvogels; Jeanne-Marie Devaster; Karl Walravens
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

8.  Refining the approach to vaccines against influenza A viruses with pandemic potential.

Authors:  Rita Czako; Kanta Subbarao
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

9.  Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review.

Authors:  Kimberly Bloom-Feshbach; Wladimir J Alonso; Vivek Charu; James Tamerius; Lone Simonsen; Mark A Miller; Cécile Viboud
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections.

Authors:  Anne Mosnier; Saverio Caini; Isabelle Daviaud; Elodie Nauleau; Tan Tai Bui; Emmanuel Debost; Bernard Bedouret; Gérard Agius; Sylvie van der Werf; Bruno Lina; Jean Marie Cohen
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.